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Dear Editors,
Today’s astronauts are highly selected and physically fit 
professionals with an average age ranging from 40 to 50 
years [5]. Age at the time of astronaut selection has gradu-
ally increased over the years [5], and future commercial 
space tourism will expose older persons with comorbidities 
to space conditions. Weightlessness elicits an acute ceph-
alad fluid shift; more chronically, cardiac atrophy and altered 
autonomic cardiovascular control [3] limit the ability of the 
cardiovascular system to cope with hemodynamic challenges 
after the astronaut’s return from space. With increasing age, 
the capacities of autonomic cardiovascular adjustments dete-
riorate [1], possibly resulting in changes in the tolerance 
to gravitational stress [10] and in physical performance. 
Increasing age of professional and recreational astronauts 
could conceivably affect the cardiovascular autonomic 
response to weightlessness. With the exception of a case 
report on orthostatic responses in a 77-year-old astronaut 
[9], studies on cardiovascular aging in astronauts are scarce. 
We had the unique opportunity to assess the cardiovascular 
responses of an older male astronaut during parabolic flights 
producing short-term weightlessness. We subsequently com-
pared these responses to measurements obtained for this 
same astronaut 20 years earlier in space.
In 1993, the male astronaut under study had spent almost 
10 days in space as crew member of the second German 
Spacelab mission D2 aboard STS-55 Space Shuttle Colum-
bia. Twenty years later, at age 62 years, he participated in a 
parabolic flight campaign. In the intervening years, he had 
remained physically active and had passed the yearly US 
National Aeronautics and Space Administration (NASA) 
medical tests for astronauts. NASA provided D2 mission 
data, and the analysis was approved by the NASA Institu-
tional Review Board (Protocol number Pro1372). The para-
bolic flight study was approved by the ethical committee of 
University Witten/Herdecke. The astronaut provided written 
informed consent including consent for this publication.
During D2, haemodynamic and cardiovascular autonomic 
testing were conducted on the astronaut in the supine posi-
tion 270 days before launch, after 4 days in space, and within 
the first week after his return to Earth. Testing included car-
diac output measurements by the acetylene gas rebreathing 
method. During the parabolic flights, we measured cardiac 
output under the 1 G and weightlessness conditions using Electronic supplementary material The online version of this article (https ://doi.org/10.1007/s1028 6-019-00657 -1) contains 
supplementary material, which is available to authorized users.
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the inert gas rebreathing method (INNOCOR®; Innovision 
ApS, Glamsbjerg, Denmark). We evaluated 57 parabolic 
flight inert gas rebreathing data sets and an identical number 
of simultaneously collected electrocardiography data sets 
and finger blood pressure tracings. We obtained measure-
ments supine at 1 G and during supine and upright transi-
tions from 1.8 G to weightlessness. The astronaut received 
100 µg scopolamine-hydrobromide subcutaneously 30 min 
before the parabolic flights to prevent motion sickness.
At the time of the D2 mission, cardiac mass was assessed 
by magnetic resonance imaging before and after spaceflight 
[7]. At the time of the parabolic flight campaign, we assessed 
cardiac structure and function through dynamic cardiovas-
cular magnetic resonance imaging.
At the time of the shuttle mission, the astronauts’s body 
mass index (BMI) was 25 kg/m2 [8]; 20 years later, it has 
increased to 29 kg/m2. Blood pressure and heart rate evolu-
tions at rest and during physical exercise over the years are 
shown in Fig. 1. Peak oxygen consumption progressively 
declined over time. Left ventricular mass was 181 g before 
and 166 g after the shuttle mission and had decreased to 
123 g 20 years later (Electronic Supplementary Material 
[ESM] Table S1). Heart rate varied in the time and fre-
quency domain while supine or during orthostatic stress 
and  changed only modestly with age. Supine low-frequency 
oscillations of systolic blood pressure were 2 mmHg2 dur-
ing the shuttle mission and 9 mmHg2 20 years later (ESM 
Table S2).
Supine cardiac output was 8.0 L·min−1 before the shut-
tle launch and 7.0 L·min−1 on flight day 4, and it remained 
reduced 7 days after the return to Earth. Total peripheral 
resistance was 822 dyn·s·cm−5 while supine at 1 G and 
1056 dyn·s·cm−5 in weightlessness (ESM Table S3). Car-
diac power output, which is derived from cardiac output and 
mean arterial pressure, was 1.45 W before and 1.45 W dur-
ing spaceflight; 20 years later, supine cardiac output at 1 G 
was 3.5 ± 0.3 L·min−1 and increased moderately with the 
transition from 1.8 G to weightlessness to 4.0 ± 0.5 L·min−1 
(p = 0.010). Total peripheral resistance was substantially 
increased while supine at 1 G and in weightlessness. During 
the parabolic flight campaign, supine cardiac power output at 
1 G was 0.46 ± 0.07 W and increased to 0.67 ± 0.09 W with 
the transition from 1.8 G to weightlessness (p < 0.001) (ESM 
Fig. S1). With standing transitions into weightlessness, 
Fig. 1  Longitudinal anthro-
pometric and cardiovascular 
data of exercise stress testing 
performed on a yearly basis 
for the astronaut flight medical 
examination. a Body mass index 
(BMI), b heart rate during rest 
in sitting position (grey graph) 
and at peak exercise capacity 
(black graph), c, d systolic (c) 
and diastolic (d) arterial pres-
sures during rest in sitting posi-
tion (grey graph) and at peak 
exercise capacity (black graph), 
e peak oxygen consumption 
(VO2 peak)
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cardiac output increased from 3.2 ± 0.4 to 6.0 ± 0.6 L·min−1, 
total peripheral resistance decreased from 1959 ± 343 to 
1034 ± 167 dyn·s·cm−5 and cardiac power output almost 
doubled (ESM Table S4).
Our findings suggest that aging-associated changes in 
cardiovascular control mechanisms and in cardiac structure 
may alter the haemodynamic response to weightlessness. 
The astronaut under study recapitulated typical aging-associ-
ated changes, including increases in pulse pressure, systemic 
vascular resistance, and blood pressure variability in the 
low-frequency range, all of which result from sympathetic 
modulation of vascular tone. Cross-sectional studies apply-
ing more direct measurements also showed increased sym-
pathetic support of vascular tone with age [4]. Conversely, 
cardiac output, cardiac power output, heart rate variability, 
and baroreflex sensitivity, while still in the physiological 
range, markedly decreased. Cardiac output tends to decrease 
after the third decade of life [2]. The combination of intrin-
sic cardiovascular aging and indirect cardiovascular effects 
of changes in physical activity and increased adiposity could 
be causative. Aging-associated changes in cardiovascular 
structure and autonomic control may have contributed to the 
profound shifts in cardiac output and power output towards 
lower levels and total peripheral resistance towards higher 
levels, both supine at 1 G and during weightlessness.
Our report has important limitations. Observations on a 
single astronaut cannot be generalized. Furthermore, meas-
urments from real space missions and parabolic flights are 
difficult to compare; for example, plasma volume tends 
to decrease over time in space. Low-dose scopolamine 
application, which has a limited effect on the cardiovascu-
lar response to parabolic flights [6], is another limitation. 
Despite these issues, our findings may have practical impli-
cations for an aging professional astronaut population and 
commercial space tourism, which will not be restricted to 
highly selected persons. Our preliminary observations, par-
ticularly the reduction in cardiac performance, provide an 
impetus for systematic studies on influences of aging on 
the cardiovascular response to weightlessness. Preserva-
tion of the cardiovascular capacity of aging astronauts is 
key to enabling human space exploration and future private 
astronautics.
Acknowledgements This work was supported by the Grants 
50WB1255 and 50WB1517 of the German Federal Ministry for Eco-
nomic Affairs and Energy. We are grateful to the German Aerospace 
Center for providing the flight opportunity during the 22nd DLR 
Parabolic Flight Campaign. We are also thankful to Wolfram Sies for 
his technical support and to the appointees of NOVESPACE for all 
their skillful help.
Authors’ contribution UL, SM, GKP, AG, PFM, PG, LEJB, HWS con-
tributed substantially to conception and design of the study. UL, SM, 
GKP, AG, PFM, PG, HWS performed data acquisition. UL, SM, JT, 
KH, FH, AG performed statistical data analysis. UL, SM, JT, GKP, 
KH, FH, AG, PFM, PG, LEJB, HWS, BDL, JJ contributed to inter-
pretation of the data of the work. UL and JJ wrote the first draft of the 
manuscript. All authors contributed to manuscript revision, read and 
approved the submitted version.
Data availability The datasets generated during and analyzed during 
the current study are not publicly available due to protect the medical 
data of the participant but are available from the corresponding author 
on reasonable request.
Compliance with ethical standards 
Conflict of interest The authors declare that they have no conflict of 
interest.
References
 1. Almeida-Santos MA, Barreto-Filho JA, Oliveira JL, Reis FP, da 
Cunha Oliveira CC, Sousa AC (2016) Aging, heart rate variability 
and patterns of autonomic regulation of the heart. Arch Gerontol 
Geriatr 63:1–8
 2. Brandfonbrener M, Landowne M, Shock NW (1955) Changes in 
cardiac output with age. Circulation 12:557–566
 3. Eckberg DL, Diedrich A, Cooke WH, et al (2016) Respiratory 
modulation of human autonomic function: long-term neuroplas-
ticity in space. J Physiol 594:5629–5646
 4. Jones PP, Shapiro LF, Keisling GA, et al (2001) Altered auto-
nomic support of arterial blood pressure with age in healthy men. 
Circulation 104:2424–2429
 5. Kovacs GTA, Shadden M (2017) Analysis of age as a factor in 
NASA astronaut selection and career landmarks. PLoS ONE 
12:e0181381
 6. Limper U, Gauger P, Beck P, Krainski F, May F, Beck LE 
(2014) Interactions of the human cardiopulmonary, hormonal 
and body fluid systems in parabolic flight. Eur J Appl Physiol 
114:1281–1295
 7. Perhonen MA, Franco F, Lane LD, et al (2001) Cardiac atrophy 
after bed rest and spaceflight. J Appl Physiol 91:645–653
 8. Prisk GK, Verhaeghe S, Padeken D, Hamacher H, Paiva M (2001) 
Three-dimensional ballistocardiography and respiratory motion in 
sustained microgravity. Aviat Space Environ Med 72:1067–1074
 9. Rossum AC, Ziegler MG, Meck JV (2001) Effect of spaceflight 
on cardiovascular responses to upright posture in a 77-year-old 
astronaut. Am J Cardiol 88:1335–1337
 10. Shibao C, Grijalva CG, Raj SR, Biaggioni I, Griffin MR (2007) 
Orthostatic hypotension-related hospitalizations in the United 
States. Am J Med 120:975–980
